Use Of Insulin-Like Growth Factor-Binding Protein 7 And Tissue Inhibitor Of Metalloproteinase 2 In The Management Of Patients At Risk For Acute Kidney Injury

Inventors: John A. Kellum Jr

Patent Number: PCT/US2017/036227

Abstract

The present invention provides methods and compositions for identifying patients at risk of kidney injury. A risk score, which is a composite of a urinary concentration of IGFBP7 (insulin-like growth factor-binding protein 7) and a urinary concentration of TIMP-2 (tissue inhibitor of metalloproteinase 2), is determined obtained from the patient, and is used to manage patient treatment.
View Google Patent Page
Download PDF